Weekly Twitter Roundup

Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:

  • The future of personal genomics? http://bit.ly/4dYwB4 @Knome-20 years “Every medicine you take will be tailored specifically to your genome”
  • Pathway Genomics Sets Discount Deal with OptumHealth Allies http://bit.ly/2R2G84 (via @gw_dailyscan)
  • Balancing Innovation, Access, and Profits — Market Exclusivity for Biologics http://bit.ly/RkUhy (via @NEJM)
  • Genomic Research Continues To Go DTC: http://bit.ly/vCNSe
  • “So…One Can Have Their Complete Genome Sequenced…Should I?” http://bit.ly/4wbh1i (from Patrice Milos of Helicos)
  • RT @dgmacarthur: Sequencing powerhouse in the East – Bio-IT World profiles the Beijing Genomics Institute: http://bit.ly/3tUkRl
  • A good example of how the “DNA mystique” infects media reporting on genetics/genomics: http://bit.ly/CTdBc
  • Missed the last year of #healthcare reform debate? Want an update on issues, not politics? @NEJM is for you http://bit.ly/3JJSP4 (HT @ahier)
  • Provisional Patents: A (Temporary) First Step: http://bit.ly/4vlHw7 (newest installment in Bench to Market series http://bit.ly/gpjr7)
  • RT @dgmacarthur Patrick Vallance (GSK): the genetics hyperbole of the 1990s has set back pharmacogenomics.
  • RT @dgmacarthur M. Skipper: Nature has 15 biology editors vs 9 physical sciences editors b/c “we live in an age of biology”
  • RT @dgmacarthur Brilliant post from @lukejostins: how many of our ancestors are related to us genetically? http://bit.ly/17tLJh
  • RT @phylogenomics Agreed but much harder – RT @EdwardWinstead $1000 genome would be interesting but $1000 microbiome would be fascinating.
  • RT @NatureNews UK to store innocents’ details on DNA database for six years http://ff.im/-biDyk #biobanking
  • To the moon: In support of the genomic astronauts who will take us there http://bit.ly/Lecly (from @jasonbobe)
  • ACLU leads coalition opposing GINA exemption for wellness programs: http://bit.ly/12sIPM Just the first in many GINA implementation battles
  • RT @PLoS 41 Nobelists, incl Varmus, write open ltr to congress supporting Federal Research Public Access Act http://tinyurl.com/nobelfrpaa
  • Also of SACGHS. When Evans talks about gene patents we should listen RT @ncbiotech UNC’s Jim Evans Talks Genetics http://ow.ly/160NeV
  • CVS Caremark, Generation Health to Expand PGx Testing to Millions: http://bit.ly/fLsql (via @gw_dailyscan)
  • RT @23andMe: comparison of personal genetics services – @GeoffShmigelsky makes his results public at http://su.pr/2LD2u9
  • Bilski and Biotechnology: The Supremes Speak Up http://bit.ly/3SuT4H
  • Disclosure of Genetic Information Without Patient Consent-Is the ‘Public Interest’ a Sufficient Justification? http://bit.ly/33uxKL
  • Genetic ‘breakthroughs’ in medicine are often nothing of the sort http://bit.ly/1EPytj Claims of research bias; what do scientwists think?
  • Post from @lindaavey on need for standardized DTC genetic risk assessment http://bit.ly/3CvkEL
  • Nature Methods paper: next-generation sequencing just one of many needed tools: http://bit.ly/1B85mc Reminds me of: http://bit.ly/3hVuDQ
  • FDA needs consistent evidentiary standards for post-market labeling to include pharmacogenetic info: http://bit.ly/2zRfVC
  • Genetic discrimination: problem or paradox? http://bit.ly/kOA1r (What ELSI is New? from @PHGFoundation)
  • RT @TimesScience: Lord Drayson: Govt will endorse sci freedom, Johnson wrong to sack David Nutt without consulting me. http://tr.im/EloG
  • RT @PHGFoundation New European and US biobanking initiatives http://bit.ly/3JxYJM